Case report and review of the literature: multiplanar CT as a supportive diagnostic tool in pleuroperitoneal leak during peritoneal dialysis Authors: Alessia Negri, Francesco Lombardi, Giampiero Facchini, Luciana Paladini, Angelo Calabrese, Annamaria Della Corte, Fabrizio Fabiani, Lorenzo Maria Tramaglino Published: 2026 ABSTRACT IntroductionPleural effusion is a recognized complication of peritoneal dialysis (PD), with pleuroperitoneal communication (PPC) representing a rare but clinically significant cause. Patients typically present with dyspnea, reduced ultrafiltration volume and edema.Case presentationA 52-year-old woman on daily peritoneal dialysis reported progressive dyspnea and chronic localized chest pain, which is an uncommon presentation. Imaging revealed a massive right-sided pleural effusion, and pleural fluid analysis showed a transudate based on Light’s criteria with markedly elevated glucose concentration. Computed tomography (CT) with multiplanar reconstruction demonstrated findings suggestive of a focal diaphragmatic discontinuity, however, the defect was not clearly visualized and no functional confirmation of pleuroperitoneal communication was achieved. Peritoneal dialysis was discontinued, and the patient was transitioned to hemodialysis (HD). The pleural effusion resolved completely in 5 days without further complications.DiscussionThis case highlights the importance of considering pleuroperitoneal communication in PD patients with pleural effusion and chest pain. Due to the absence of a clearly defined gold standard, the diagnosis can be challenging. A key diagnostic marker for pleuroperitoneal leak is an elevated glucose concentration in the pleural fluid. Several imaging techniques can aid diagnosis but generally suffer from relatively low sensitivity.ConclusionPleuroperitoneal leak is a rare but severe complication of PD. According to our experience, CT with multiplanar reconstruction provided anatomical findings suggestive of a diaphragmatic defect, and, in addition to pleural fluid biochemical analysis, helped strengthen the diagnostic suspicion of PPC. However, further studies comparing imaging findings with surgical confirmation are needed to determine its true diagnostic accuracy and its reliability in identifying the diaphragmatic defect. Introduction Peritoneal dialysis (PD) is a therapeutic option for the treatment of end-stage renal failure but may cause both infectious and non-infectious complications. Pleural effusion in patients undergoing PD can have multiple causes, including hypervolemia, parapneumonic effusions and uremic pleuritis (1). Pleuroperitoneal leak is a rare complication of PD with an incidence less than 2% (2). This phenomenon results from the transdiaphragmatic passage of dialysate into the pleural space, typically on the right side (2–4), through congenital or acquired defects in the diaphragm. It is generally an early complication, with 89% of reported cases occurring within 12 months (5), but delayed presentations have also been reported (6). Patients may present with non-specific symptoms such as dyspnea and progressive reduction in ultrafiltration volumes, but atypical presentations have also been reported, such as syncopal episode (4). Diagnosis relies on a combination of biochemical analysis of pleural fluid—often revealing a transudate with high glucose concentration (7)—and advanced imaging techniques such as peritoneal scintigraphy or computed tomography peritoneography (CTP). We report the case of a patient on daily peritoneal dialysis who presented with acute dyspnea and chronic localized pain. Non-contrast chest CT revealed a massive right-sided pleural effusion and pleural fluid biochemical test showed high glucose level compared to serum glucose. To further support the clinical suspicion of pleuroperitoneal communication, we performed multiplanar reconstruction of the chest CT. The pleural effusion resolved completely with the cessation of peritoneal dialysis and transition to hemodialysis (Table 1). Table 1Timeline of clinical events, diagnostic procedures, and management during the patient’s course.TimeEventMonth 0Start of PD.Month 9Onset of chronic chest pain and exertional dyspnea.Month 12Onset of rest dyspnea and ED admission.Day 1 of hospitalizationDiagnosis of pleural effusion and chest drain placement.Day 5 of hospitalizationMultiplanar reconstruction of the chest CT suggested diaphragmatic defect. PD discontinued, switch to HD.Day 10 of hospitalizationUltrasound evaluation showed resolution of the pleural effusion and chest drain was removed.Subsequent monthsContinued on HD without further complications. Timeline of clinical events, diagnostic procedures, and management during the patient’s course. Moreover, a narrative literature review was performed using the PubMed database, applying the following keywords: ‘pleuroperitoneal leak’, ‘pleuroperitoneal communication’, ‘computed tomography peritoneography’, and ‘pleural effusion’ in association with ‘peritoneal dialysis’. An initial comprehensive search covering the last 20 years was conducted, followed by a focused selection of studies published within the last 5 years based on their relevance to diagnostic approaches and clinical management (Table 2). Table 2Literature review of reported cases of pleuroperitoneal leak in peritoneal dialysis patients.Author (year)PresentationDiagnosisTreatmentOutcomeCho et al. 2010 (16)Dyspnea, right pleuritic chest painChest X-ray, biochemical PF tests, peritoneal scintigraphyPD discontinued and converted temporary to HD, VATS + pleurodesisResumed PDBae et al. 2011 (9)Dry coughChest X-ray, biochemical PF tests, CT peritoneographyPD discontinuation and converted to HDOn HDKennedy et al. 2011 (15)Three cases:DyspneaDyspnea, weight gain, lower limb edemaNot specified Chest X-ray, biochemical PF testsChest X ray, biochemical PF testsBiochemical PF tests, imaging not specified PD discontinuationTherapeutic thoracentesis, PD discontinuedChest drain, PD discontinued, VATS with decortication On HDOn HDOn HD Hojs et al. 2019 (40)Reduced ultrafiltration volumes, tachydyspneaChest X-ray, biochemical PF testsPD discontinued and converted temporary to HDResumed PDNakayama et al. 2019 (23)DyspneaChest X-ray, CT peritoneographyVATS with surgical correction of the defectResumed PDDang et al. 2020 (33)Reduced ultrafiltration volumes, dyspnea, tachypnea and hypoxiaChest X-ray, biochemical PF testsVATS + pleurodesisResumed PDBohra et al. 2020 (14)DyspneaChest X-ray, biochemical PF tests, peritoneal scintigraphyTherapeutic thoracentesis, PD discontinued and converted to hemodialysisOn HDNewallo et al. 2022 (20)Dyspnea, chest painChest X-ray, biochemical PF tests, low-dose SPECT/CT in peritoneal scintigraphyTherapeutic thoracentesis, PD discontinued, switched to HDOn HDWang et al. 2023 (4)Syncopal episode, worsening fatigue, poor appetite, difficult-to-control moderate hypertensionChest CT, biochemical PF testsPD discontinuedOn HDKwan et al. 2023 (6)Dyspnea and reduced ultrafiltration volumesChest X-ray, biochemical PF tests, peritoneal scintigraphyPD discontinued and converted to hemodialysisOn HDJonny et al. 2024 (34)Dyspnea and dry coughChest X-ray, biochemical PF tests and peritoneal scintigraphyVATS with surgical correction of the defect + pleurodesisResumed PDBhattarai et al. 2024 (41)DyspneaChest X-ray, biochemical PF testsTherapeutic thoracentesis, PD discontinued and converted to HDOn HDShah et al. 2024 (27)Dyspnea, tachypnea, reduced ultrafiltration volumesChest X-ray, chest CT, biochemical PF testsTherapeutic thoracentesis, PD discontinued and converted to HDOn HDGarcía Romero et al. 2024 (28)Dyspnea, hypoxia, pleuritic pain secondary to PD sessionsChest X-ray, chest CT, methylene blue instillation testConverted to HDOn HDRia et al. 2025 (19)2 patients: Dyspnea and reduced ultrafiltration volumesChest X-ray, peritoneal scintigraphy + CT peritoneography PD discontinued and converted to HDVATS with surgical correction of the defect On HDResumed PD Lafrid et al. 2025 (35)Dyspnea, reduced ultrafiltration volumes, lower limbs edema, weight gainChest X-ray, biochemical PF tests, CT peritoneographyVATS + pleurodesisResumed PDSuyama et al. 2025 (32)Dyspnea, persistent coughChest X-ray, peritoneal scintigraphyVATS with surgical correction of the defectResumed PDPresent case (2025)Exertional and rest dyspnea, chronic and localized chest painBiochemical PF tests, chest CT with multiplanar reconstructionPD discontinued and converted to HDOn HDPD, peritoneal dialysis; HD, hemodialysis; CT, computed tomography; VATS, video-assisted thoracoscopic surgery; PF, pleural fluid. Literature review of reported cases of pleuroperitoneal leak in peritoneal dialysis patients. Dyspnea Dyspnea Dyspnea, weight gain, lower limb edema Dyspnea, weight gain, lower limb edema Not specified Not specified Chest X-ray, biochemical PF tests Chest X-ray, biochemical PF tests Chest X ray, biochemical PF tests Chest X ray, biochemical PF tests Biochemical PF tests, imaging not specified Biochemical PF tests, imaging not specified PD discontinuation PD discontinuation Therapeutic thoracentesis, PD discontinued Therapeutic thoracentesis, PD discontinued Chest drain, PD discontinued, VATS with decortication Chest drain, PD discontinued, VATS with decortication On HD On HD On HD On HD On HD On HD PD discontinued and converted to HD PD discontinued and converted to HD VATS with surgical correction of the defect VATS with surgical correction of the defect On HD On HD Resumed PD Resumed PD PD, peritoneal dialysis; HD, hemodialysis; CT, computed tomography; VATS, video-assisted thoracoscopic surgery; PF, pleural fluid. Case presentation A 52-year-old Caucasian woman with end-stage chronic kidney disease and a single functioning kidney on daily automated peritoneal dialysis (APD) from approximately 12 months using a portable home-based dialysis device, presented to the emergency department (ED) with progressive dyspnea and chronic localized right-sided chest pain. She reported that the chest pain had started approximately 9 months after the initiation of peritoneal dialysis and had been present for 4 months at the time of presentation. She denied fever or cough and reported that dyspnea started as exertional and then gradually worsened in rest dyspnea. She also had a medical history of myelodysplastic syndrome, vasculopathy with bilateral optic nerve stroke and hypertension. Family history was unremarkable for renal, pulmonary, or hereditary disorders. The patient reported no history of smoking or alcohol abuse. Physical examination revealed decreased breath sounds over the entire right hemithorax, with dullness to percussion and absent vocal fremitus. Oxygen saturation was normal (95% on ambient air), and arterial blood gas analysis showed compensated metabolic acidosis (pH 7.43, PaO2 79 mmHg, PaCO2 27.6 mmHg, HCO3–17.9 mmol/L, BE −5.4 mmol/L, Lactate 1.25 mmol/L). Blood tests demonstrated mild anemia (Hemoglobin 9.5 g/dL), elevated serum creatinine (9.8 mg/dL), and normal inflammatory markers. Electrocardiogram and bedside echocardiography excluded acute cardiac pathology, showing preserved ejection fraction and no evidence of pericardial effusion. A non-contrast chest CT scan revealed a massive right-sided pleural effusion with almost complete atelectasis of the underlying lung. The patient underwent ultrasound-guided placement of a chest drain with pleural fluid notable for its appearance, closely resembling cerebrospinal fluid (Figure 1). Pleural fluid appearance. Biochemical analysis of the pleural fluid showed a markedly elevated glucose level (223 mg/dL) in the absence of hyperglycemia (serum glucose 86 mg/dL), very low protein content (0.3 g/dL), and low lactate dehydrogenase (35 U/L), consistent with a transudative effusion. Cytological examination ruled out malignant cells, and all microbiological cultures were negative. These findings raised clinical suspicion for a pleuroperitoneal leak of dialysis fluid. We performed multiplanar reconstruction of the chest CT, which revealed a focal area of suspected diaphragmatic discontinuity. However, the defect was not clearly visualized, and no direct evidence of dialysate passage across the diaphragm could be demonstrated. Therefore, imaging findings were considered suggestive but not diagnostic of pleuroperitoneal communication (Figures 2–4). Coronal chest CT showing a suspected diaphragmatic discontinuity (white arrow). Sagittal CT reconstruction demonstrating a focal area suggestive of diaphragmatic discontinuity of the right hemidiaphragm (white arrow). Axial CT images showing the same region of diaphragmatic irregularity (white arrow). Peritoneal dialysis was immediately discontinued due to the strong clinical suspicion of PPC. The patient was transitioned to intermittent hemodialysis via central venous access as a renal replacement strategy. No additional pleural interventions were required after initial chest drainage. Five days after cessation of PD, bedside thoracic ultrasound showed complete resolution of the pleural effusion. The rapid resolution of the pleural effusion after discontinuation of PD was compatible with the suspected diagnosis and offered indirect clinical corroboration of pleuroperitoneal communication. Over the subsequent months and to date, the patient continued on HD without further complications. The patient reported significant anxiety related to months of unexplained chronic pain. She described rapid symptomatic relief after discontinuation of peritoneal dialysis and expressed satisfaction with the diagnostic process and outcome. Written informed consent for publication was obtained from the patient. Discussion Pleural effusion represents a reported complication of peritoneal dialysis, and its occurrence has been associated with adverse clinical outcomes in dialysis populations, including increased morbidity and mortality (8). Pleural effusion typically presents with non-specific symptoms such as shortness of breath, cough, lower limbs edema, weight gain and reduced ultrafiltration volumes. Also 25% of patients remain completely asymptomatic (9). We described an atypical presentation with chronic and localized chest pain as the main symptom, in association with dyspnea. Wang et al. (4) also reported an unusual case presenting with an isolated syncopal episode and fatigue without the other commonly observed symptoms. In patients with end-stage renal disease, pleuroperitoneal communication must be differentiated from other common causes of pleural effusion, including fluid overload, congestive heart failure, and pneumonia. The pathophysiological mechanism involves a PPC caused by a defect in the diaphragm that allows the translocation of dialysate from a positive pressure district (abdomen) into a negative pressure district (pleural cavity). Pleural effusion due to diaphragmatic defect is usually an early complication of PD with 76% of reported cases occurring within 6 months and 89% within 12 months (4, 5). In a single-centre retrospective study, the mean duration of PD before symptoms onset was 177.0 ± 101.1 days (3). Our case occurred after approximately 12 months of PD, however a case has also been reported in which pleuroperitoneal leak presented after 15 months (6). The variability in both clinical presentation and timing of onset, along with the lack of clearly defined diagnostic gold standards, makes this condition challenging to diagnose. Biochemical analysis of pleural fluid is a key diagnostic marker to differentiate a dialysate leak from other causes of transudative effusion. Chow et al. compared the biochemical analysis of pleural fluid in seven cases of pleural effusion secondary to pleuroperitoneal leak and found that a fluid-to-serum glucose gradient exceeding 50 mg/dL is highly sensitive of PPC (7). Alahmad et al. reported a specificity of 100% for this cut off value (10). Other reports have suggested that a pleural fluid–to–serum glucose ratio >1.0 may also be highly specific (11–13); however, variability in reported cases highlights the absence of a uniform biochemical pattern. Accordingly, no universally accepted diagnostic threshold has been established. For instance, Bohra et al. described a case in which the glucose gradient was <50 mg/dL with a fluid-to-serum glucose ratio >1.0 (14), but in a recent retrospective series, Cao et al. found that only 6 of 9 patients had a pleural fluid–to–serum glucose ratio >1, while 3 patients had a ratio <1 (3). Kennedy et al. (15) also reported a case in which biochemical analysis of pleural fluid did not reveal elevated glucose levels. In our case the pleural fluid was transudative according to Light’s criteria, with a pleural-to-serum glucose ratio of 2.59 and a glucose gradient of 137 mg/dL. The markedly elevated glucose level was highly suggestive of dialysate contamination, especially in the absence of hyperglycemia. Radiological assessment can aid diagnosis but has low sensitivity. Chest X-ray can detect pleural effusion, but not the diaphragmatic defect. Radionuclide peritoneal scintigraphy typically performed using Tc-99 m–labeled agents, represents one of the most commonly employed diagnostic technique. It allows functional demonstration of dialysate migration from the peritoneal cavity into the pleural space and has reported sensitivities ranging from 40 to 50% (16–18). In one study this method could detect the presence of PPC in 70% of cases with majority within 12 minutes following contrast injection (5). However, while scintigraphy provides functional confirmation of pleuroperitoneal communication, it does not reliably localize the site of the diaphragmatic defect. For this reason and to improve diagnostic sensitivity, combined imaging approaches have been proposed. Ria et al. reported the use of peritoneal scintigraphy in association with CT peritoneography to achieve defect localization, which was subsequently confirmed during surgery (19). Newallo et al. reported the use of low-dose SPECT/CT integrated into peritoneal scintigraphy, performed using a low-volume (100 mL) normal saline and Tc-99 m sulfur colloid. In their case, SPECT/CT successfully detected the leakage whereas conventional scintigraphy did not, thereby improving sensibility (20). Another option is CT peritoneography (CTP), performed after intraperitoneal instillation of iodinated contrast diluted in dialysate, which can provide combined functional and anatomical information and may aid diagnosis especially when the defect is large, with a reported sensitivity of 40–50% (21). Consistently, in a retrospective study, Cao et al. reported a sensitivity of 50% when CT was acquired 4 h after intraperitoneal contrast infusion (3). CTP has shown good sensitivity also in detecting atypical fistulous pathways, such as retroperitoneal routes (22); however, further systematic studies are needed to define its accuracy in localizing the diaphragmatic defect. Multiple technical factors may influence diagnostic sensitivity, including the intraperitoneal volume and pressure, patient position, and breath-holding during image acquisition; suboptimal conditions may reduce the transdiaphragmatic pressure gradient and result in failure to demonstrate the pleuroperitoneal leak (23, 24). In terms of procedural safety, CT peritoneography does not significantly affect residual renal function, with no meaningful changes in estimated glomerular filtration rate (eGFR) observed before and after the procedure in a recent retrospective study (3). According to Prischl et al. magnetic resonance imaging (MRI) using only dialysate as the “contrast medium” can be another useful diagnostic tool; nevertheless, evidence remains limited and largely derives from case reports (25). In our case, non-contrast chest CT with multiplanar reconstruction was performed to further investigate the suspected diaphragmatic defect. Multiplanar reconstructions (MPr) are routinely integrated into modern CT reporting workstations and can be performed without additional equipment, making them a readily accessible tool in routine clinical settings (26). However, CT provides only anatomical information and does not directly demonstrate active dialysate leakage. Accordingly, in our case, the imaging findings were only suggestive and not diagnostic of a diaphragmatic defect, as the discontinuity was not clearly visualized and no direct evidence of transdiaphragmatic passage could be demonstrated. In the absence of surgical exploration, the focal discontinuity observed on our multiplanar CT reconstruction cannot be conclusively established as the true site of PPC and the accuracy of defect localization cannot therefore be reliably determined. Similarly, Shah et al. also reported a case of pleuroperitoneal communication in which the diaphragmatic defect was visible on conventional chest CT; however, management was conservative, without surgical confirmation of the defect (27). In addition to conventional imaging techniques, contrast-enhanced ultrasonography has recently been explored as a potential diagnostic adjunct. Inanaga et al. described the use of thoracic ultrasound following intraperitoneal instillation of dialysate mixed with 4.0 μL of perflubutane, in a case where CT peritoneography had failed to identify the leakage site (24). Although the ultrasound findings confirmed PPC, precise defect localization was not possible. Nevertheless, this technique is minimally invasive, low-cost, and widely available, suggesting that further studies are warranted to evaluate its potential role as an additional diagnostic tool in the workup of PPC. Beyond imaging modalities, methylene blue instillation through the peritoneal dialysis catheter has been described as a simple diagnostic adjunct, allowing functional confirmation of pleuroperitoneal communication through observation of dye in pleural drainage (28, 29). In a recent report, Romero et al. employed this technique to confirm pleuroperitoneal communication; notably, the diaphragmatic fistula was also identifiable on CT imaging in the same case. However, management was conservative, and no surgical exploration was performed; therefore, confirmation of the diagnosis and precise localization of the fistula relied on response to treatment rather than intraoperative validation (28). Evidence suggests that imaging accuracy is largely determined by defect size and position: larger defects are more likely to be identified, whereas smaller central tendon discontinuities—frequently described in operative reports (30)—may remain radiologically occult (24). However, the diagnosis of pleuroperitoneal communication should not rely on imaging findings alone but rather on the integration of clinical presentation, pleural fluid biochemical analysis and radiological assessment. In our case, the unilateral right-sided effusion in association with the elevated glucose concentration in pleural fluid provided strong evidence supporting the diagnosis. In this context, CT findings were interpreted as complementary anatomical information. The subsequent rapid resolution of the pleural effusion following discontinuation of peritoneal dialysis further supported the diagnostic coherence of this integrated approach. Although CTP and radionuclide peritoneal scintigraphy remain the preferred diagnostic modalities due to their ability to provide functional confirmation of PPC, their availability may be limited in routine clinical practice; in contrast, CT with multiplanar reconstruction is widely accessible, easy and rapid to perform and can provide relevant anatomical clues. Moreover, in selected patients—particularly those who are not candidates for surgical repair or decline invasive procedures—functional confirmation may not be strictly required, and a presumptive diagnosis can be reasonably supported by the integration of CT findings with pleural fluid biochemistry, clinical context, and resolution after temporary discontinuation of peritoneal dialysis - as observed in our case. The present report does not aim to demonstrate a diagnostic superiority of CT over established functional imaging modalities, but rather to highlight its potential role as a readily available adjunct in selected clinical scenarios. Management of pleuroperitoneal communication typically begins with prompt interruption of peritoneal dialysis and transition to hemodialysis for 2 to 6 weeks (7, 31). In our patient, this approach was chosen because of the patient’s preference to avoid surgical intervention and led to the complete and rapid resolution of the pleural effusion and the associated symptoms without the need for additional interventions. Temporary cessation of peritoneal dialysis may lead to spontaneous healing of the PPC in selected cases, especially in the presence of small defects, and may permit resumption of peritoneal dialysis. Nevertheless, the recurrence of this complication remains unpredictable, and continuation of PD, without surgical correction, has been rarely reported (7). The patient’s decision to resume or not peritoneal dialysis is a key factor in determining how to manage the PPC. In contemporary series, surgical management most commonly consists of video-assisted thoracoscopic surgery (VATS) with direct identification and repair of the diaphragmatic defect, using suturing, stapling, or patch reinforcement. This approach has been associated with high success rates, frequently exceeding 80–90%, and often allows safe resumption of peritoneal dialysis (14, 22, 29, 32–36). To improve intraoperative defect localization, several strategies have been described, including pneumoperitoneum-based approaches and intraperitoneal dye instillation. Indigo carmine and indocyanine green (ICG), sometimes combined with near-infrared imaging, have been employed during thoracoscopic repair to enhance detection of diaphragmatic defects and guide surgical closure (28, 30, 32, 37). However, even VATS exploration may occasionally fail to localize the defect, reflecting the anatomical heterogeneity of PPC and the frequent presence of small or multiple fenestrations, which are typically described as minute, bleb-like lesions located within the central tendon of the diaphragm (23, 24, 30). Successful identification of the diaphragmatic defect appears to strongly correlate with surgical outcomes. Saito et al. (38) reported a success rate of 89% when the diaphragmatic defect was clearly identified and repaired, compared with only 38% when localization was unsuccessful. Accordingly, Inanaga et al. described a case in which CT peritoneography and intraoperative exploration with indigo carmine did not reveal the leakage site. The diaphragm was coated with polyglycolic acid sheets and fibrin glue; however, recurrence occurred 6 months later, further emphasizing the prognostic importance of precise defect localization (24). In addition, pleurodesis represents another established therapeutic option, with a reported efficacy of approximately 50% (39). Chemical pleurodesis may be performed either through thoracic drainage or during VATS, using agents such as talc, hypertonic glucose, or autologous blood. This strategy aims to obliterate the pleural space and prevent recurrent dialysate leakage, particularly in cases where the defect cannot be clearly identified intraoperatively. Cao et al. described intrapleural elemene infusion, administered via the thoracic drainage tube after complete evacuation of the pleural effusion in a cohort of 12 patients, with recurrence observed in only three cases during follow-up (3). Wang et al. reported a case managed with VATS and direct repair of the diaphragmatic defect combined with pleurodesis and subsequent Pseudomonas aeruginosa instillation into the pleural cavity in order to promote pleural adhesion. No perioperative complications were described, peritoneal dialysis was successfully resumed, and no recurrence was observed during follow-up (29). However, these approaches have been reported only in isolated reports and require further systematic evaluation before being considered standard therapeutic options. Conclusion Pleuroperitoneal communication is an uncommon but important cause of pleural effusion in PD patients. Clinical presentation may be variable and occasionally atypical, as in our case, where chronic localized chest pain accompanied dyspnea. Diagnosis requires an integration of clinical, biochemical, and radiological data. Although chest CT with multiplanar reconstruction cannot provide functional confirmation of active leakage, in our experience it may offer useful anatomical findings suggestive of diaphragmatic discontinuity and contribute to the overall diagnostic assessment, particularly when interpreted within a strongly supportive biochemical and clinical context. Definitive localization of the defect, however, remains dependent on surgical confirmation. Early recognition of PPC and prompt interruption of peritoneal dialysis are essential to achieve rapid resolution of pleural effusion. However, current evidence suggests that VATS with direct repair of the diaphragmatic defect has the highest efficacy in preventing recurrence and enabling safe resumption of peritoneal dialysis.